The Chart That Explains RTX's Backlog-to-Multiple Problem

Historically, defence primes have traded at a forward P/E 2-4 multiple points above their 10-year average when the backlog-to-revenue ratio exceeds 2.5x. The ratio captures two things: the visibility into forward revenue and the pricing power the backlog commits. RTX's 2.7x today compares to a 10-year average of 1.9x, with the excess driven by the post-2022 order surge across both the Pratt & Whitney commercial aerospace book and the Raytheon defence book. Between 2010 and 2024, six defence primes touched a backlog-to-revenue ratio above 2.5x. In five of those six cases, the forward twelve-month total return exceeded the sector average. The one miss was the early-2019 Boeing print, which was obviously company-specific. That base rate matters for position sizing: the ratio today is closer to 2.7x than to 2.5x, and the order intake rate is still accelerating, not decelerating.

The compounding mechanics inside the ratio are the real story. Every dollar added to the backlog at current book-to-bill ratios is a dollar that converts to revenue over a three-to-seven-year delivery window. At the current intake pace of roughly $100 billion annually, the backlog will expand faster than revenue for another 12-18 months before the conversion cycle catches up. That is the window the forward multiple is pricing.

The 2023 margin collapse is easy to read: the Pratt & Whitney powder-metal fleet management cost charge absorbed roughly $3 billion of operating income in that single year. That charge is now in the rear-view mirror. What the market has not yet priced is the accelerating conversion of the Raytheon defence segment's backlog, which carries structurally higher margins than the commercial aerospace book. As Raytheon's mix share rises through 2026-2027, the consolidated operating margin trend accretes another 100-150 basis points. Build it explicitly. Raytheon's share of total segment EBIT was 38% in 2025; on backlog conversion trajectories, that share rises toward 43% by 2027. The segment carries a gross margin approximately 300 basis points above Pratt & Whitney's commercial book. A 500 basis point mix shift at consolidated margins lifts RTX's operating margin by roughly 80-100 basis points. That mechanical accretion, combined with volume-driven operating leverage on a $90-plus billion revenue base, is worth $0.75-1.00 of incremental EPS over two years.

The counter-argument is that Pratt & Whitney's commercial aerospace recovery disappoints, or that supply-chain cost inflation re-opens the margin gap. The data is pointing the other direction. Q1 2026 commercial aftermarket shop visits tracked ahead of internal forecasts, and the supply-chain cost curve has stabilised since late 2024. Neither dynamic is priced into the current multiple; both compound the upside case.

On the trajectory implied by the backlog, 2027 free cash flow should sit in the $9-10 billion range. At today's market cap of $264 billion, that is a free cash flow yield of 3.4-3.8%. Against a 10-year defence-prime average FCF yield of 4.2%, the stock is trading slightly rich on trailing numbers but slightly cheap on forward numbers. The 2027 convergence is the trade. There is a working-capital dynamic inside the FCF number worth calling out. During the Pratt fleet-management cycle, progress payments and inventory builds absorbed approximately $3 billion of working capital above historical norms. That absorption is reversing, which is why the 2025 FCF print jumped to $7.9 billion. The reversal has 18-24 months left to run. Every dollar of that working-capital release adds directly to cash flow without requiring any revenue or margin improvement.

For a defence prime priced at 3.4% forward FCF yield against a 10-year sector average of 4.2%, the math is clear: either the stock re-rates down to the sector FCF yield average or cash flow grows into the multiple. The backlog says cash flow grows into the multiple. That is the trade.

The $12 billion Lockheed-RTX Germany naval contract is a useful template. Of that $12 billion, RTX's share flows through the Raytheon segment, spread across a seven-year delivery window with escalator clauses indexed to inflation. Contracts of this structure typically convert at a 15-17% operating margin at the net-of-escalator level. The Germany deal on its own adds roughly $1.5-1.8 billion of incremental 2027-2030 revenue at high-single-digit operating margin contribution. Scaled across the pipeline, RTX's forward book has approximately $40 billion of contract value in active negotiations that could close within 18 months. Germany is the template; similar multi-year international defence procurements are in discussion with the UK, Poland, Italy and two Pacific-basin allies. If even half of that pipeline converts, the backlog grows by another $20 billion over the next 18 months while revenue is still running at current levels. The ratio stretches from 2.7x toward 2.9x. The sector re-rates accordingly.

One point worth emphasising: these international contracts carry different margin dynamics than domestic defence procurements. Foreign military sales contracts typically include higher escalator clauses and more protective pricing structures. The incremental gross margin on international defence work is approximately 200-300 basis points above the Raytheon segment average. Mix accretion on that incremental $20 billion of contract value is worth another $400-600 million of operating income over a five-to-seven-year delivery window.

Historically, defence primes exiting a backlog build cycle like this one have produced sustained revenue acceleration for four to six quarters before the cycle peaks. The 2003-2007 post-9/11 buildup produced Lockheed revenue growth of 7-12% annually for five consecutive years. The current backlog ratio puts RTX roughly at the entry point of a similar conversion window. The chart on forward revenue growth is the one investors should be building. The 2003-2007 parallel has some differences worth acknowledging. That cycle was funded by US defence spending acceleration off a recently-peaked base. Today's cycle is driven by Europe (NATO 2% of GDP floor), Pacific-basin allies, and a long-tail commercial aerospace recovery. The funding diversity is structurally better than the 2003-2007 cycle, which means the duration of the conversion window may be longer rather than shorter. The stock's forward multiple implies a 3-4 year acceleration window; the data could easily support 5-6 years.

A second historical lens: Lockheed's 2012-2015 window, during which backlog-to-revenue rose from 1.8x to 2.4x, produced a 95% total return for shareholders despite a demanding forward multiple at cycle entry. The current RTX setup shares more characteristics with that Lockheed cycle than with any other modern defence prime comparable.

The 50-day moving average at $200 sits above the 200-day at $177, with the gap widening through 2026. Beta of 0.43 captures the defensive nature of the book. The 52-week high of $214.50 is the next resistance. Given the backlog-to-revenue ratio and the margin accretion trajectory, the next twelve-month total return profile looks asymmetric to the upside. The chart-driven view is that the current multiple is fair on trailing numbers and cheap on forward numbers. There is a volume profile signal worth flagging. Institutional 13F data shows net buying across the top 20 long-only defence investors for four consecutive quarters, with the largest cluster of additions occurring in the $175-190 range. That implies a strong technical support zone on any pullback. Above that, the daily volume-weighted average price has been trending upward since Q3 2025 without any major gap structures, suggesting orderly accumulation rather than retail chasing.